Antiallergic drugs and quality of life.
Allergic diseases represent a global health problem with a substantial impact on medical costs and socioeconomic outcomes. Furthermore, as well documented in the recent literature, these pathologies also have negative consequences on the functional, emotional and psychosocial aspects of daily life. Using validated and standardized tools, it is possible to evaluate individual outcomes. At present, the health-related quality of life parameter is used in clinical trials, population studies and public health, providing a comprehensive picture of both the disease and its treatment on the quality of life. While many studies have addressed this topic in respiratory allergy, further studies are needed to explore the use of health-related quality of life both before and after treatment in other allergic conditions such as dermatitis, eczema, urticaria and food allergy.
Baiardini
Ilaria
I
Allergy and Respiratory Diseases, DIMI, University of Genoa, Pad. Maragliano, L.go R. Benzi 10, 16132 Genoa, Italy. ilaria.baiardini@libero.it
Fumagalli
Federica
F
Braido
Fulvio
F
Pasquali
Mercedes
M
Canonica
Giorgio Walter
GW